Stocktoria

Tevogen Bio Holdings Inc. TVGN

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-11-04

Tevogen Bio Holdings Inc. statistics & valuation

Market cap$29.5M

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
2.4M 120.0M 3.6M 4.0M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
1.20% -1098.50% -396.60% -599.50% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$2.44 -$3.50 -$8.08 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-599.5%-396.6%-1098.5%1.2%
Return on equity319.1%205.7%64.0%-13.0%
Current ratio0.220.260.020.78

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.